Amgen, the world's largest biotech drug maker, said late Tuesday its board voted unanimously to end the company's "poison pill" plan early.
The shareholder rights plan designed to thwart a hostile takeover will now expire on July 31.
The plan was originally set to expire on Dec. 12, 2010.
No comments:
Post a Comment